BRPI0520041A2 - processo e métodos para a preparação de cis-2-hidroximetil-4- ( citosin-1' - il) - 1,3-oxatiolano oticamente ativo ou sais derivados farmaceuticamente aceitáveis - Google Patents
processo e métodos para a preparação de cis-2-hidroximetil-4- ( citosin-1' - il) - 1,3-oxatiolano oticamente ativo ou sais derivados farmaceuticamente aceitáveisInfo
- Publication number
- BRPI0520041A2 BRPI0520041A2 BRPI0520041-5A BRPI0520041A BRPI0520041A2 BR PI0520041 A2 BRPI0520041 A2 BR PI0520041A2 BR PI0520041 A BRPI0520041 A BR PI0520041A BR PI0520041 A2 BRPI0520041 A2 BR PI0520041A2
- Authority
- BR
- Brazil
- Prior art keywords
- hydroxymethyl
- preparation
- methods
- pharmaceutically acceptable
- optically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2005/000384 WO2006096954A1 (en) | 2005-03-14 | 2005-03-14 | Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1´-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0520041A2 true BRPI0520041A2 (pt) | 2009-04-14 |
Family
ID=36991222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0520041-5A BRPI0520041A2 (pt) | 2005-03-14 | 2005-03-14 | processo e métodos para a preparação de cis-2-hidroximetil-4- ( citosin-1' - il) - 1,3-oxatiolano oticamente ativo ou sais derivados farmaceuticamente aceitáveis |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1866303B1 (pt) |
JP (1) | JP5001254B2 (pt) |
KR (1) | KR100993031B1 (pt) |
CN (1) | CN101142211B (pt) |
AP (1) | AP2261A (pt) |
AU (1) | AU2005329355B8 (pt) |
BR (1) | BRPI0520041A2 (pt) |
CA (1) | CA2599825C (pt) |
ES (1) | ES2446102T3 (pt) |
IL (1) | IL185370A0 (pt) |
MX (1) | MX2007011274A (pt) |
NI (1) | NI200700235A (pt) |
NO (1) | NO338553B1 (pt) |
NZ (1) | NZ560972A (pt) |
WO (1) | WO2006096954A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110257396A1 (en) * | 2006-10-30 | 2011-10-20 | Lupin Limited | Process for the manufacture of cis(-)-lamivudine |
IN2015DN02599A (pt) | 2007-09-28 | 2015-09-18 | Avexa Ltd | |
EP2358708B1 (en) * | 2008-12-08 | 2013-06-12 | Hetero Research Foundation | Optical resolution of substituted 1.3-oxathiolane nucleosides |
WO2011141805A2 (en) | 2010-05-14 | 2011-11-17 | Lupin Limited | An improved process for the manufacture of lamivudine |
JP2012136526A (ja) * | 2012-02-09 | 2012-07-19 | Shire Canada Inc | 光学的に活性なcis−2−ヒドロキシメチル−4−(シトシン−1’−イル)−1,3−オキサチオランまたはその薬学的に許容される塩の製造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2095613C (en) * | 1990-11-13 | 2001-01-02 | Bernard Belleau | Substituted 1, 3-oxathiolanes and substituted 1, 3-dithiolanes with antiviral properties |
US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US6228860B1 (en) | 1990-11-13 | 2001-05-08 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
NZ241625A (en) * | 1991-02-22 | 1996-03-26 | Univ Emory | 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers |
US6600044B2 (en) * | 2001-06-18 | 2003-07-29 | Brantford Chemicals Inc. | Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers |
-
2005
- 2005-03-14 JP JP2008501117A patent/JP5001254B2/ja not_active Expired - Fee Related
- 2005-03-14 MX MX2007011274A patent/MX2007011274A/es active IP Right Grant
- 2005-03-14 NZ NZ560972A patent/NZ560972A/en not_active IP Right Cessation
- 2005-03-14 EP EP05714624.3A patent/EP1866303B1/en active Active
- 2005-03-14 AP AP2007004147A patent/AP2261A/xx active
- 2005-03-14 BR BRPI0520041-5A patent/BRPI0520041A2/pt not_active IP Right Cessation
- 2005-03-14 CN CN2005800490781A patent/CN101142211B/zh not_active Expired - Fee Related
- 2005-03-14 WO PCT/CA2005/000384 patent/WO2006096954A1/en active Application Filing
- 2005-03-14 AU AU2005329355A patent/AU2005329355B8/en not_active Ceased
- 2005-03-14 KR KR1020077022748A patent/KR100993031B1/ko not_active IP Right Cessation
- 2005-03-14 CA CA2599825A patent/CA2599825C/en not_active Expired - Fee Related
- 2005-03-14 ES ES05714624.3T patent/ES2446102T3/es active Active
-
2007
- 2007-08-20 IL IL185370A patent/IL185370A0/en not_active IP Right Cessation
- 2007-09-11 NI NI200700235A patent/NI200700235A/es unknown
- 2007-10-11 NO NO20075224A patent/NO338553B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2005329355B2 (en) | 2011-08-18 |
CN101142211B (zh) | 2013-06-05 |
AP2261A (en) | 2011-07-26 |
AU2005329355A1 (en) | 2006-09-21 |
NO20075224L (no) | 2007-10-11 |
NZ560972A (en) | 2009-07-31 |
KR20080008322A (ko) | 2008-01-23 |
MX2007011274A (es) | 2008-03-13 |
WO2006096954A1 (en) | 2006-09-21 |
EP1866303A1 (en) | 2007-12-19 |
ES2446102T3 (es) | 2014-03-06 |
EP1866303B1 (en) | 2013-11-27 |
KR100993031B1 (ko) | 2010-11-08 |
CA2599825A1 (en) | 2006-09-21 |
AP2007004147A0 (en) | 2007-10-31 |
IL185370A0 (en) | 2008-02-09 |
CA2599825C (en) | 2012-06-19 |
EP1866303A4 (en) | 2010-05-19 |
NI200700235A (es) | 2012-05-23 |
AU2005329355B8 (en) | 2012-02-23 |
NO338553B1 (no) | 2016-09-05 |
JP2008533056A (ja) | 2008-08-21 |
JP5001254B2 (ja) | 2012-08-15 |
CN101142211A (zh) | 2008-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012008020B8 (pt) | máquina de perfuração. | |
EA200800886A1 (ru) | Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов | |
BRPI0520041A2 (pt) | processo e métodos para a preparação de cis-2-hidroximetil-4- ( citosin-1' - il) - 1,3-oxatiolano oticamente ativo ou sais derivados farmaceuticamente aceitáveis | |
NZ599342A (en) | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | |
CO6331461A2 (es) | Proceso de preparacion de derivados del acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico | |
WO2009066735A1 (ja) | 2-アザアダマンタン類の製造方法 | |
EA201071120A1 (ru) | Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида | |
IL185545A0 (en) | Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors | |
ATE466003T1 (de) | Herstellung von 2-aminothiazol-5- carbonsäurederivaten | |
DK2060568T3 (da) | Polymorfer af enantiomerisk ren erdostein | |
EA201001252A1 (ru) | Способ получения производных 3,6-дигидро-1,3,5-триазина | |
WO2010097802A3 (en) | A process for the preparation of etoricoxib | |
ITMI20030578A1 (it) | Processo ed intermedi per la preparazione di emtricitabina | |
ATE523490T1 (de) | Verfahren zur herstellung von pleuromutilinen | |
DE602006002650D1 (de) | Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat | |
EA201071025A1 (ru) | Способ получения [фенилсульфанилфенил]пиперидинов | |
DE602005013007D1 (de) | Verfahren zur herstellung von lactonen | |
MY146568A (en) | Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof | |
ATE538102T1 (de) | Verfahren zur herstellung eines chinazolinderivats | |
ATE456572T1 (de) | Verfahren zum herstellen von lysobactin-derivaten | |
CO6280533A2 (es) | Proceso para preparar un compuesto intermedio para sintetizar un antiulcerante | |
EA200900982A1 (ru) | Новый способ синтеза прамипексола и его фармацевтически приемлемых солей | |
DE602004022874D1 (de) | Biotransformation von colchicinoidverbindungen | |
IL185635A0 (en) | Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives | |
BR112012015708A2 (pt) | novo processo para produção de 4-aminobut-2-enolidas a partir de 4-alcoxifuran-2 (5h) -ona ou 4-arilalcoxfuran-2 (5h) -ona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: SHIRE BIOCHEM INC (CA) Free format text: AFIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 018100030210/SP DE 18/08/2010, E NECESSARIO REAPRESENTAR O DOCUMENTO DE ALTERACAO DEVIDAMENTE CONSULARIZADO. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: SHIRE CANADA INC. (CA) |
|
B25E | Requested change of name of applicant rejected |
Owner name: SHIRE CANADA INC. (CA) Free format text: INDEFERIDO(S) O(S) PEDIDO(S) DE ALTERACAO(OES) DE NOME CONTIDO(S) NA PETICAO NO 18100030210, DE 18/08/2010, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2125, DE 27/09/2011. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2505 DE 08-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |